5 results
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Pathophysiology Anticoagulation ... (e.g. rivaroxaban ... warfarin) for chronic anticoagulation ... accelerates the bridging ... - Rivaroxaban
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
Oral anticoagulant ... dosing and bridging ... #VTE #DOAC #Bridging ... #Anticoagulation ... Dabigatran #Apixaban #Rivaroxaban
Choice of anticoagulant for treatment of pulmonary embolism
 • Malignancy - LMWH
 • To avoid parenteral
Choice of anticoagulant ... parenteral therapy - Rivaroxaban ... oral therapy - Rivaroxaban ... reversal agent - VKA, UFH ... decisionaid #vte #anticoagulation
Effect of Anticoagulants on Coagulation Tests
PT / INR, aPTT, Anti-Xa Activity, Activated Clotting Time, Thrombin Time,
Effect of Anticoagulants ... Time Warfarin UFH ... Fondaparinux Rivaroxaban ... EricsMedicalLectures/ #Anticoagulants ... #Tests #Anticoagulation
Anticoagulant Bridging

 • Switching from LMWH
 • Switching from UFH
 • Switching from DOAC to Warfarin
Anticoagulant Bridging ... Switching from UFH ... Warfarin to DOAC (No Bridging ... Kfischer_10 #Anticoagulant ... #Bridging #anticoagulation